Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients
Launched by POWER LIFE SCIENCES INC. · Jun 2, 2023
Trial Information
Current as of June 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into the experiences of patients with pulmonary fibrosis when they participate in clinical studies. The goal is to find out what factors make it harder for certain groups of patients to join or complete these trials. By gathering and analyzing information from a diverse range of patients, the researchers hope to uncover patterns that could help improve the experience for future patients with pulmonary fibrosis.
To be eligible for this study, participants need to be at least 18 years old and have a diagnosis of pulmonary fibrosis. They should also be able to understand the study's procedures and sign a consent form agreeing to participate. However, individuals who are already involved in another research study or cannot provide consent will not be able to take part. Those who join can expect to share their experiences and insights, which could lead to better support and resources for pulmonary fibrosis patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient is at least 18 years of age
- • Diagnosis of pulmonary fibrosis
- • Ability to understand the study procedures, benefits and risks, and sign a written informed consent document.
- Exclusion Criteria:
- • Enrolled in another research study
- • Inability to provide written informed consent
- • Women of childbearing potential without a negative pregnancy test; or women who are lactating.
About Power Life Sciences Inc.
Power Life Sciences Inc. is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutic solutions across various medical disciplines. With a strong emphasis on scientific rigor and patient-centered approaches, the organization collaborates with leading researchers and healthcare professionals to design and execute clinical trials that prioritize safety, efficacy, and compliance. Power Life Sciences Inc. leverages cutting-edge technology and data analytics to streamline trial processes, enhance participant engagement, and accelerate the development of life-changing treatments, ultimately aiming to improve patient outcomes and contribute to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Michael B Gill
Study Director
Power Life Sciences Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported